Kranias Chairs NIH Study Section
Litsa Kranias, PhD, Hanna Professor, Distinguished University Research Professor in the Department of Pharmacology and Cell Biophysics and Co-Director of the Cardiovascular Center of Excellence, has been appointed Chair of the Cardiac Contractility, Hypertrophy and Heart Failure (CCHF) study section of the National Institutes of Health. The appointment is until July 2017. Section chairs are chosen on the basis of their demonstrated leadership in the field, strong record of NIH funding and scholarly publications, broad scientific perspective, reputation for integrity and fairness, respect by the scientific review officers panel, willingness to support NIH review policies, and the ability to appropriately manage meetings, review presentations and summarize discussion. The CCHF Study Section reviews applications to the NIH that involve basic, applied and translational aspects of heart function, homeostasis and disease. Applications focus on contractile function and dysfunction, including studies of hereditary and acquired cardiac hypertrophy and failure, at levels ranging from molecular assemblies to the intact organ to translation of novel therapies to human.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.